Novavax delays U.S. trial of Covid-19 vaccine candidate to November
Novavax on Tuesday delayed the start of a late-stage U.S. trial of its experimental coronavirus vaccine by roughly a month to the end of November, citing delays in scaling up the manufacturing process.
The U.S.-based drug developer said!-->!-->!-->…
Read More...
Read More...